Development and Use of Gene Therapy Orphan Drugs—Ethical Needs for a Broader Cooperation Between the Pharmaceutical Industry and Society
Gene therapy orphan medicinal products constitute a unique group of new drugs which in case of hereditary diseases are usually administered only once at an early age, in the hope to provide sufficient gene product to last for the entire life of the patients. The combination of an exceptionally large...
Main Authors: | Sandor Kerpel-Fronius, Varvara Baroutsou, Sander Becker, Roberto Carlesi, Luis Collia, Brigitte Franke-Bray, Peter Kleist, Chieko Kurihara, Luis Filipe Laranjeira, Kotone Matsuyama, Shehla Naseem, Johanna Schenk, Honorio Silva |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2020.608249/full |
Similar Items
-
Corrigendum: Linking the Declarations of Helsinki and of Taipei: Critical Challenges of Future-Oriented Research Ethics
by: Chieko Kurihara, et al.
Published: (2021-02-01) -
Linking the Declarations of Helsinki and of Taipei: Critical Challenges of Future-Oriented Research Ethics
by: Chieko Kurihara, et al.
Published: (2020-10-01) -
The Evolution of AIFA Registries to Support Managed Entry Agreements for Orphan Medicinal Products in Italy
by: Entela Xoxi, et al.
Published: (2021-08-01) -
Comparison of vulnerability of orphaned adolecsents to non-orphaned adolescents in the rural Hlabisa district of South Africa
by: Adam, Ahmed G.M.
Published: (2012) -
Evidence supporting regulatory-decision making on orphan medicinal products authorisation in Europe: methodological uncertainties
by: Caridad Pontes, et al.
Published: (2018-11-01)